EDWARD TIMINSKI: Open Payments
NPI 1083140016 · WHITINSVILLE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$680 in 26 payments from 5 companies in 2025. Trend: 2023 $2,603 · 2024 $875 · 2025 $680
Food & beverage: $680
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $247 |
| Otsuka America Pharmaceutical, Inc. | 11 | $199 |
| E.R. Squibb & Sons, L.L.C. | 5 | $116 |
| Lundbeck LLC | 4 | $92 |
| Axsome Therapeutics, Inc. | 1 | $25 |
Products named: REXULTI, CAPLYTA, COBENFY, Auvelity.
Industry payments across MA — which companies pay providers there.
